EGFR and cancer: The underlying mechanism of hypomagnesium and this favorable response toward cancer treatment is lacking and not well elucidated21, and it is inferred that hypomagnesemia induces upregulation of EGFR ligands as magnesiotropic hormone, which in turn, makes tumor more susceptible to anti-EGFR MoAs14,16,39.